Press "Enter" to skip to content

FDA Guidance on Conduct of Clinical Trials of Medical Products During the Public Health Emergency

John Concato, MD, MS MPH, acting associate director of real-world evidence analytics in the Office of Medical Policy, discusses the creation of the FDA guidance “Conducting Clinical Trails of Medical Products During the COVID-19 Public Health Emergency and the opening of the mailbox; and their role in promoting the safety of trial participants, maintaining compliance with good clinical practice, and minimizing risks to trial integrity.

Learn More at:

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  

Upcoming Training –
SBIA Listserv –
SBIA 2021 Playlist –
SBIA LinkedIn –
SBIA Training Resources –
Twitter –
Email –
Phone – (301) 796-6707 I (866) 405-5367